Literature DB >> 31833668

Lung deposition of nebulized surfactant in newborn piglets: Nasal CPAP vs Nasal IPPV.

Anders Nord1, Rikard Linner1, Fabrizio Salomone2, Federico Bianco2, Francesca Ricci2, Xabi Murgia3, Martin Schlun4, Doris Cunha-Goncalves1, Valeria Perez-de-Sa1.   

Abstract

BACKGROUND: Nasal continuous positive airway pressure support (nCPAP) is the standard of care for prematurely born infants at risk of neonatal respiratory distress syndrome (nRDS). However, nasal intermittent positive pressure ventilation (NIPPV) may be an alternative to nCPAP in babies requiring surfactant, and in conjunction with surfactant nebulization, it could theoretically reduce the need for invasive mechanical ventilation. We compared lung deposition of nebulized poractant in newborn piglets supported by nCPAP or NIPPV.
METHODS: Twenty-five sedated newborn piglets (1.2-2.2 kg) received either nCPAP (3 cmH2 O, n = 12) or NIPPV (3 cmH2 O positive end expiratory pressure+3 cmH2 O inspiratory pressure, n = 13) via custom-made nasal prongs (FiO2 0.4, Servo-i ventilator). Piglets received 200 mg kg-1 of technetium-99m-surfactant mixture continuously nebulized with a customized eFlow-Neos investigational vibrating-membrane nebulizer system. Blood gases were taken immediately before, during, and after nebulization. The deposition was estimated by gamma scintigraphy.
RESULTS: Mean surfactant deposition in the lungs was 15.9 ± 11.9% [8.3, 23.5] (mean ± SD [95% CI]) in the nCPAP group and 21.6 ± 10% [15.6, 27.6] in the NIPPV group (P = .20). Respiratory rates were similar in both groups. Minute volume was 489 ± 203 [360, 617] in the nCPAP group and 780 ± 239 [636, 924] mL kg-1  min-1 in the NIPPV group (P = .009). Blood gases were comparable in both groups.
CONCLUSION: Irrespective of the noninvasive ventilatory support mode used, relatively high lung deposition rates of surfactant were achieved with nebulization. The amounts of deposited surfactant might suffice to elicit a pulmonary function improvement in the context of nRDS.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  aerosols; nebulizer; neonatal; noninvasive ventilation

Year:  2019        PMID: 31833668     DOI: 10.1002/ppul.24603

Source DB:  PubMed          Journal:  Pediatr Pulmonol        ISSN: 1099-0496


  9 in total

1.  Advancement of the Infant Air-Jet Dry Powder Inhaler (DPI): Evaluation of Different Positive-Pressure Air Sources and Flow Rates.

Authors:  Connor Howe; Mohammad A M Momin; Dale R Farkas; Serena Bonasera; Michael Hindle; P Worth Longest
Journal:  Pharm Res       Date:  2021-08-30       Impact factor: 4.580

2.  In Vitro Analysis of Nasal Interface Options for High-Efficiency Aerosol Administration to Preterm Infants.

Authors:  Connor Howe; Mohammad A M Momin; Karl Bass; Ghali Aladwani; Serena Bonasera; Michael Hindle; Philip Worth Longest
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2022-02-14       Impact factor: 3.440

3.  Development of a High-Dose Infant Air-Jet Dry Powder Inhaler (DPI) with Passive Cyclic Loading of the Formulation.

Authors:  Connor Howe; Mohammad A M Momin; Ghali Aladwani; Michael Hindle; P Worth Longest
Journal:  Pharm Res       Date:  2022-10-17       Impact factor: 4.580

4.  Preclinical Assessment of Nebulized Surfactant Delivered through Neonatal High Flow Nasal Cannula Respiratory Support.

Authors:  Francesca Ricci; Arianna Mersanne; Matteo Storti; Marcello Nutini; Giulia Pellicelli; Angelo Carini; Ilaria Milesi; Marta Lombardini; Raffaele L Dellacà; Merran A Thomson; Xabier Murgia; Anna Lavizzari; Federico Bianco; Fabrizio Salomone
Journal:  Pharmaceutics       Date:  2022-05-20       Impact factor: 6.525

5.  Nebulized Poractant Alfa Reduces the Risk of Respiratory Failure at 72 Hours in Spontaneously Breathing Surfactant-Deficient Newborn Piglets.

Authors:  Carmen Rey-Santano; Victoria E Mielgo; Miguel Angel Gomez-Solaetxe; Federico Bianco; Fabrizio Salomone; Begoña Loureiro
Journal:  Crit Care Med       Date:  2020-06       Impact factor: 7.598

6.  Extended Pharmacopeial Characterization of Surfactant Aerosols Generated by a Customized eFlow Neos Nebulizer Delivered through Neonatal Nasal Prongs.

Authors:  Federico Bianco; Elena Pasini; Marcello Nutini; Xabier Murgia; Carolin Stoeckl; Martin Schlun; Uwe Hetzer; Sauro Bonelli; Marta Lombardini; Ilaria Milesi; Marisa Pertile; Stephan Minocchieri; Fabrizio Salomone; Albert Bucholski
Journal:  Pharmaceutics       Date:  2020-04-02       Impact factor: 6.321

Review 7.  Aerosol drug delivery to spontaneously-breathing preterm neonates: lessons learned.

Authors:  Federico Bianco; Fabrizio Salomone; Ilaria Milesi; Xabier Murgia; Sauro Bonelli; Elena Pasini; Raffaele Dellacà; Maria Luisa Ventura; Jane Pillow
Journal:  Respir Res       Date:  2021-02-26

Review 8.  Aerosol Delivery of Lung Surfactant and Nasal CPAP in the Treatment of Neonatal Respiratory Distress Syndrome.

Authors:  Frans J Walther; Alan J Waring
Journal:  Front Pediatr       Date:  2022-06-15       Impact factor: 3.569

9.  Initial Development of an Air-Jet Dry Powder Inhaler for Rapid Delivery of Pharmaceutical Aerosols to Infants.

Authors:  Connor Howe; Michael Hindle; Serena Bonasera; Vijaya Rani; P Worth Longest
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2020-08-04       Impact factor: 2.849

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.